View of Platelet-to-lymphocyte ratio as a predictor of 5-year prognosis in patients with gastrointestinal stromal tumors receiving imatinib

Return to Article Details Platelet-to-lymphocyte ratio as a predictor of 5-year prognosis in patients with gastrointestinal stromal tumors receiving imatinib Download Download PDF